{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:25:38Z","timestamp":1788258338141,"version":"build-2803163510"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Injection drug use poses a public health challenge. Clinical experience indicates that people who inject drugs (PWID) are hospitalized frequently for infectious diseases, but little is known about outcomes when admitted. Charts were identified from local hospitals between 2013\u20132018 using consultation lists and hospital record searches. Included individuals injected drugs in the past six months and presented with infection. Charts were accessed using the hospital information system, undergoing primary and secondary reviews using Research Electronic Data Capture (REDCap). The Wilcoxon rank-sum test was used for comparisons between outcome categories. Categorical data were summarized as count and frequency, and compared using Fisher\u2019s exact test. Of 240 individuals, 33% were admitted to the intensive care unit, 36% underwent surgery, 12% left against medical advice (AMA), and 9% died. Infectious diagnoses included bacteremia (31%), abscess (29%), endocarditis (29%), cellulitis (20%), sepsis (10%), osteomyelitis (9%), septic arthritis (8%), pneumonia (7%), discitis (2%), meningitis\/encephalitis (2%), or other (7%). Sixty-six percent had stable housing and 60% had a family physician. Fifty-four percent of patient-initiated discharges were seen in the emergency department within 30 days and 29% were readmitted. PWID are at risk for infections. Understanding their healthcare trajectory is essential to improve their care.<\/jats:p>","DOI":"10.1371\/journal.pone.0266663","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T17:31:33Z","timestamp":1650475893000},"page":"e0266663","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID)"],"prefix":"10.1371","volume":"17","author":[{"given":"Jacqueline","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sureka","family":"Pavalagantharajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P","family":"Verschoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Smieja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Mbuagbaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Eric","family":"Tarride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cvetkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"van Gaalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4698-7536","authenticated-orcid":true,"given":"Aidan Reid","family":"Findlater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Bassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Lokker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2333-0144","authenticated-orcid":true,"given":"Elizabeth","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"pone.0266663.ref001","unstructured":"City of Hamilton Public Health Services. Hamilton supervised injection site needs assessment and feasibility study. 2017. Available from: https:\/\/www.hamilton.ca\/city-initiatives\/strategies-actions\/supervised-injection-site-needs-assessment-feasibility-study."},{"key":"pone.0266663.ref002","article-title":"Blueprint to Inform Hepatitis C Elimination Efforts in Canada.","author":"The Canadian Network on Hepatitis C Blueprint Writing Committee and Working Groups.","year":"2019","journal-title":"CanHepC"},{"key":"pone.0266663.ref003","article-title":"The epidemiology of HIV in people who inject drugs in Canada","author":"L. Challacombe","year":"2018","journal-title":"CATIE"},{"key":"pone.0266663.ref004","unstructured":"Public Health Agency of Canada. Summary of key findings from I-TRACK phase 3 (2010\u20132012). Government of Canada. 2014 [Cited 2018 October 17]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/hiv-aids\/publications\/summary-key-findings-i-track-phase-3-2010-2012.html."},{"issue":"16","key":"pone.0266663.ref005","article-title":"A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada.","volume":"14","author":"CE Kendall","year":"2017","journal-title":"Harm Reduct J"},{"key":"pone.0266663.ref006","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","article-title":"Hospitals as a \u2018risk environment\u2019: An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs.","volume":"105","author":"R McNeil","year":"2014","journal-title":"Soc Sci Med"},{"issue":"12","key":"pone.0266663.ref007","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","article-title":"Leaving the hospital against medical advice among people who use illicit drugs: A systematic review.","volume":"105","author":"L Ti","year":"2015","journal-title":"Am J Public Health"},{"issue":"Suppl III","key":"pone.0266663.ref008","first-page":"iii56","article-title":"Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS","volume":"82","author":"L Degenhardt","year":"2006","journal-title":"Sex Transm Infect"},{"key":"pone.0266663.ref009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1471-2458-8-405","article-title":"Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.","volume":"8","author":"E Lloyd-Smith","year":"2008","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0266663.ref010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2105\/AJPH.2012.300819","article-title":"Predictors of active injection drug use in a cohort of patients infected with Hepatitis C Virus.","volume":"103","author":"C Reed","year":"2015","journal-title":"Am J Public Health"},{"issue":"9","key":"pone.0266663.ref011","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/09540121.2018.1434121","article-title":"Trends in discharges from the HIV\/AIDS ward at a tertiary Canadian hospital from 2005 to 2014.","volume":"30","author":"D Jaworsky","year":"2018","journal-title":"AIDS Care"},{"issue":"1","key":"pone.0266663.ref012","doi-asserted-by":"crossref","DOI":"10.1186\/1742-5573-8-1","article-title":"WINPEPI updated: computer programs for epidemiologists and their teaching potential","volume":"8","author":"J. Abramson","year":"2011","journal-title":"Epidemiol Perspect Innov"},{"key":"pone.0266663.ref013","first-page":"10328","article-title":"The REDCap consortium: Building an international community of software partners.","volume":"95","author":"REDCap Consortium","year":"2019","journal-title":"J Biomed Inform"},{"key":"pone.0266663.ref014","unstructured":"R Core Team. The R Project for Statistical Computing. [Cited 2018 October 10]. Available from: https:\/\/www.r-project.org\/."},{"issue":"9","key":"pone.0266663.ref015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/09540121.2015.1032205","article-title":"Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting","volume":"27","author":"B Joseph","year":"2015","journal-title":"AIDS Care"},{"issue":"3","key":"pone.0266663.ref016","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11524-011-9562-9","article-title":"Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.","volume":"88","author":"A Palepu","year":"2011","journal-title":"J Urban Health"},{"issue":"4","key":"pone.0266663.ref017","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugpo.2012.03.006","article-title":"Needle Exchange and the HIV Epidemic in Vancouver: Lessons Learned from 15 years of research.","volume":"23","author":"E Hysha","year":"2012","journal-title":"Int J Drug Policy"},{"issue":"3","key":"pone.0266663.ref018","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa074","article-title":"In-Hospital Illicit Drug Use and Patient-Directed Discharge: Barriers to Care with Patients With Infection-Related Infectious.","volume":"7","author":"EF Eaton","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"pone.0266663.ref019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2105\/AJPH.2019.305379","article-title":"Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.","volume":"110","author":"B Jacka","year":"2019","journal-title":"Am J Public Health"},{"issue":"19","key":"pone.0266663.ref020","doi-asserted-by":"crossref","DOI":"10.14745\/ccdr.v40i19a02","article-title":"Estimated prevalence of Hepatitis C Virus Infection in Canada, 2011.","volume":"40","author":"M Trubnikov","year":"2014","journal-title":"Can Commun Dis Rep"},{"key":"pone.0266663.ref021","unstructured":"Millson P, Leonard, L, Remis RS, Strike C, Challacombe L. Injection Drug Use, HIV and HCV Infection in Ontario: The Evidence 1992 to 2004. Aids Bureau, Ontario Ministry of Health and Long Term Care. Available from: https:\/\/www.researchgate.net\/publication\/254608418_Injection_Drug_Use_HIV_and_HCV_Infection_in_Ontario_The_Evidence_1992_to_2004."},{"issue":"8","key":"pone.0266663.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2019-035188","article-title":"Health programs and services addressing the prevention and management of infectious diseases in persons who inject drugs in Canada: a systematic integrative review protocol","volume":"10","author":"E Alvarez","year":"2020","journal-title":"BMJ Open"},{"key":"pone.0266663.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2150132720908370","article-title":"Implementation of HIV Preexposure Prophylaxis in a Homeless Primary Care Setting at the Veterens Affairs.","volume":"11","author":"E Gregg","year":"2020","journal-title":"J Prim Care Community Health"},{"issue":"55","key":"pone.0266663.ref024","article-title":"Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.","volume":"15","author":"KB Biello","year":"2018","journal-title":"Harm Reduct J"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0303576","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T21:59:22Z","timestamp":1714082362000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266663"}},"subtitle":[],"editor":[{"given":"Yu Mon","family":"Saw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0266663","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0303576","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]}}}